1. Home
  2. SLNO vs SYNA Comparison

SLNO vs SYNA Comparison

Compare SLNO & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SYNA
  • Stock Information
  • Founded
  • SLNO 1999
  • SYNA 1986
  • Country
  • SLNO United States
  • SYNA United States
  • Employees
  • SLNO N/A
  • SYNA N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SYNA Computer peripheral equipment
  • Sector
  • SLNO Health Care
  • SYNA Technology
  • Exchange
  • SLNO Nasdaq
  • SYNA Nasdaq
  • Market Cap
  • SLNO 2.3B
  • SYNA 2.0B
  • IPO Year
  • SLNO 2014
  • SYNA 2002
  • Fundamental
  • Price
  • SLNO $69.98
  • SYNA $49.07
  • Analyst Decision
  • SLNO Strong Buy
  • SYNA Buy
  • Analyst Count
  • SLNO 8
  • SYNA 10
  • Target Price
  • SLNO $95.75
  • SYNA $96.67
  • AVG Volume (30 Days)
  • SLNO 2.6M
  • SYNA 687.7K
  • Earning Date
  • SLNO 05-08-2025
  • SYNA 05-08-2025
  • Dividend Yield
  • SLNO N/A
  • SYNA N/A
  • EPS Growth
  • SLNO N/A
  • SYNA N/A
  • EPS
  • SLNO N/A
  • SYNA 4.20
  • Revenue
  • SLNO N/A
  • SYNA $1,009,600,000.00
  • Revenue This Year
  • SLNO N/A
  • SYNA $13.20
  • Revenue Next Year
  • SLNO N/A
  • SYNA $10.04
  • P/E Ratio
  • SLNO N/A
  • SYNA $11.67
  • Revenue Growth
  • SLNO N/A
  • SYNA N/A
  • 52 Week Low
  • SLNO $36.61
  • SYNA $41.80
  • 52 Week High
  • SLNO $74.00
  • SYNA $98.00
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 62.10
  • SYNA 37.81
  • Support Level
  • SLNO $57.01
  • SYNA $46.37
  • Resistance Level
  • SLNO $71.00
  • SYNA $50.88
  • Average True Range (ATR)
  • SLNO 5.29
  • SYNA 4.23
  • MACD
  • SLNO -0.08
  • SYNA -0.17
  • Stochastic Oscillator
  • SLNO 76.34
  • SYNA 31.89

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. Geographically, it derives a majority of revenue from China. The company operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products.

Share on Social Networks: